Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Healthcare Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

Bullboard (TSX:RVX)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Post by seanj1on Mar 18, 2021 9:09pm

Apabetalone’s Beneficial Effects on COVID-19 Published in ..

Well by the time this gets to the final hurdle, Covid 19 will be a thing of the past as far as pandemic goes, eventhough it will be around for a while like a flu. Also the current management team is ...more  
317
Discussion
Comment by narmacon Mar 17, 2021 5:35pm

RE:RE:Cell peer reviewed

,,,if only we had some talent to grab the bull by the horns here and get the process in motion asap. The executives cheques keep on rolling in so they be in no real hurry,,,,,and we seem always to be ...more  
195
Discussion
Comment by ENEMENEMYNEMOon Mar 17, 2021 9:42am

RE:RE:Cell peer reviewed

RVX won't need a business partner if their drug works against COVID!  .... maybe just to distribute it! We'll be in $20sp range.  What bothers me is that they have been sitting on ...more  
278
Discussion
Comment by G1945Von Mar 17, 2021 8:46am

RE:Cell peer reviewed

The open-label study to assess the safety and efficacy of apabetalone in the treatment of COVID-19 needs to happen soon.  Its success may be instrumental in getting BP interested in RVX ...more  
193
Discussion
Post by snobeion Mar 17, 2021 8:21am

Cell peer reviewed

https://www.resverlogix.com/investors/news?article=694
229
Discussion
Comment by ENEMENEMYNEMOon Mar 16, 2021 1:38pm

RE:RE:RE:WA-POST, why not?!?!

Ahhh that makes more sense! Thanks for the klarifluckation....
151
Discussion
Comment by general360on Mar 16, 2021 9:15am

RE:RE:WA-POST, why not?!?!

ur right enemyofgeneral, i completely forgot to use the free stockhouse spell checker! i cleaned the message up for u: fkuck off and die a slow miserable investing death in RVX! (darn spel chek ...more  
199
Discussion
Post by narmacon Mar 16, 2021 7:47am

Epigenetic susceptibility to severe respiratory viral infect

This abstract seems to indicate epigenetic medicine is one avenue to fight a vast number of diseases we are faced with. Is this a start to seeing attention paid to epigenetics? Can our team of experts ...more  
202
Comment by ENEMENEMYNEMOon Mar 15, 2021 9:02pm

RE:WA-POST, why not?!?!

I would suggest Spell Check in the future...
155
Discussion
Comment by narmacon Mar 15, 2021 6:32pm

RE:WA-POST, why not?!?!

Good job there g360,,,hope they give it consideration,,,,,,I sent the info around HIV and Apabetalone to the Bill & Melinda Gates Foundation,,,I did receive a reply,,,albeit the standard cordial ...more  
194
Discussion
Post by opsd1on Mar 15, 2021 6:26pm

Resverlogix Treatment Prevents COVID-19...

https://themarketherald.ca/apabetalone-treatment-prevents-covid-19-infection-of-human-lung-cells-2021-03-15/?utm_source=stockhouse.com&utm_medium=widget&utm_campaign=stockhouse.com%7Cwebpart ...more  
197
Comment by snobeion Mar 15, 2021 4:21pm

RE:WA-POST, why not?!?!

Opponent to propopent (i know justified critic. Me too) good on ya. Maybe just maybe, despite el ducie's somewhat... this dog slowly grows some legs. Hurry up Don...covid therapies r a tickin ...more  
193
Discussion
Post by general360on Mar 15, 2021 4:09pm

WA-POST, why not?!?!

well, color me inspired by all the talk over at agoracommie.  ive sent the following to the Washington Post - Health and Science Editor and the Deputy.  Im sure i could write quite a bit ...more  
316
Discussion
Post by snobeion Mar 15, 2021 11:42am

ALSO ZENITH NR

https://agoracom.com/ir/ZenithEpigenetics/forums/discussion/topics/757314-zenith-epigenetics-announces-dosing-of-first-mcrpc-patient-with-a-combination-of-zen-3694-merck-s-immune-check-point-inhibitor ...more  
199
Post by G1945Von Mar 15, 2021 11:13am

ABL Treatm't Prevents COVID-19 Infection of Human Lung Cells

Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral CALGARY, Alberta, March 15, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX ...more  
155
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities